Related Experiment Video
Updated: Jun 2, 2026
09:49
Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
Kinase activity profiling of pneumococcal pneumonia.
Arie J Hoogendijk1, Sander H Diks, Tom van der Poll
1Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. a.j.hoogendijk@amc.uva.nl
Plos One
|April 13, 2011
Summary
This study reveals key kinase signaling pathways involved in pneumonia, identifying reduced WNT and CDK activity. These findings offer insights into host defense and potential therapeutic targets for bacterial pneumonia.
Area of Science:
- Immunology
- Molecular Biology
- Systems Biology
Background:
- Pneumonia poses a significant global health challenge.
- Effective host defense requires controlled inflammation during infection.
- Kinases are crucial regulators of inflammatory responses in immune cells.
Purpose of the Study:
- To investigate intracellular signaling pathways in bacterial pneumonia using a systems biology approach.
- To identify specific kinase activities altered during Streptococcus pneumoniae infection.
- To explore potential therapeutic targets for community-acquired pneumonia.
Main Methods:
- Induction of pneumonia in a mouse model using Streptococcus pneumoniae.
- Kinomics peptide arrays to analyze kinase activity across 1024 specific sequences.
- Validation of kinase activity changes using western blot on lung homogenates.
Main Results:
- Identified cascades of activated kinases, indicating chemotoxic stress and a T helper 1 response.
- Observed a significant reduction in WNT pathway activity in infected lungs.
- Demonstrated a decrease in overall Cyclin-Dependent Kinase (CDK) activity, suggesting cell cycle alterations.
Conclusions:
- Systems biology analysis provides novel insights into signaling events during lung infection.
- Findings highlight the role of specific kinase pathways in the host response to bacterial pneumonia.
- This research may aid in discovering new therapeutic strategies for treating bacterial pneumonia.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...